Hunt; Charleen

Patent Applications and Registrations

Patent applications and USPTO patent grants for Hunt; Charleen.The latest application filed is for "cas-ready mouse embryonic stem cells and mice and uses thereof".

Company Profile

9.3.14

Hunt; Charleen - Montvale NJ
Hunt; Charleen - Dumont NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Cas-ready Mouse Embryonic Stem Cells And Mice And Uses Thereof App 20210392862 - Gong; Guochun ; et al.	2021-12-23
Cas-ready mouse embryonic stem cells and mice and uses thereof Grant 11,130,999 - Gong , et al. September 28, 2	2021-09-28
Methods And Compositions For Assessing Crispr/cas-mediated Disruption Or Excision And Crispr/cas-induced Recombination With An Exogenous Donor Nucleic Acid In Vivo App 20210261985 - Gong; Guochun ; et al.	2021-08-26
Methods and compositions for assessing CRISPER/Cas-mediated disruption or excision and CRISPR/Cas-induced recombination with an exogenous donor nucleic acid in vivo Grant 11,021,719 - Gong , et al. June 1, 2	2021-06-01
Transcription Modulation In Animals Using Crispr/cas Systems Delivered By Lipid Nanoparticles App 20210079394 - HUNT; CHARLEEN ; et al.	2021-03-18
Rodent Model Of Mood Disorders App 20200229409 - Drummond Samuelson; Meghan ; et al.	2020-07-23
Fibrillin-1 Mutations For Modeling Neonatal Progeroid Syndrome With Congenital Lipodystrophy App 20200107527 - Hunt; Charleen ; et al.	2020-04-09
Fibrillin-1 mutations for modeling neonatal progeroid syndrome with congenital lipodystrophy Grant 10,548,302 - Hunt , et al. Fe	2020-02-04
Transcription Modulation In Animals Using Crispr/cas Systems App 20190284572 - Hunt; Charleen ; et al.	2019-09-19
Methods And Compositions For Assessing Crispr/cas-mediated Disruption Or Excision And Crispr/cas-induced Recombination With An Exogenous Donor Nucleic Acid In Vivo App 20190032092 - Gong; Guochun ; et al.	2019-01-31
Cas-ready Mouse Embryonic Stem Cells And Mice And Uses Thereof App 20190032155 - Gong; Guochun ; et al.	2019-01-31
Methods And Compositions For Assessing Crispr/cas-induced Recombination With An Exogenous Donor Nucleic Acid In Vivo App 20190032156 - Gong; Guochun ; et al.	2019-01-31
Fibrillin-1 Mutations For Modeling Neonatal Progeroid Syndrome With Congenital Lipodystrophy App 20180027782 - Hunt; Charleen ; et al.	2018-02-01
Methods And Compositions For Targeted Genetic Modification Using Paired Guide Rnas App 20160145646 - Frendewey; David ; et al.	2016-05-26
Methods And Compositions For The Targeted Modification Of A Genome App 20160060657 - Frendewey; David ; et al.	2016-03-03
Methods and Compositions for the Targeted Modification of a Genome App 20150159174 - Frendewey; David ; et al.	2015-06-11
Methods And Compositions For The Targeted Modification Of A Genome App 20150159175 - Frendewey; David ; et al.	2015-06-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.